Company / Free Cash Flow per Share
KYNTRA BIO, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$34.25
FY2025
5-year range
-$34.25 / $0.84
FY2021-FY2025
Trend
-965.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -965% YoY in FY2025, a notable deviation from the 9-year average annual change of -299%.
Based on SEC 10-K filings.
-34.25 in FY2025.
Declined from $-0.93 to $-34.25 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- KYNTRA BIO, INC.'s free cash flow per share has declined for 3 consecutive years.
- In FY2025, free cash flow per share decreased 965.3% year-over-year.
- Peak free cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$34.25 | -965.3% |
| FY2024 | -$3.21 | -246.3% |
| FY2023 | -$0.93 | -211.1% |
| FY2022 | $0.84 | +190.5% |
| FY2021 | -$0.92 | +3.8% |
| FY2020 | -$0.96 | -9.4% |
| FY2019 | -$0.88 | -1337.0% |
| FY2018 | $0.07 | +122.0% |
| FY2017 | -$0.32 | -239.9% |
| FY2016 | $0.23 | -28.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026